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Real-time NMR investigations of triple-helix folding and collagen
folding diseases
Jean Baum1 and Barbara Brodsky2
Folding of the collagen triple helix provides an
opportunity to look at multichain molecular assembly.
This triple helix also offers unique advantages for the
study of folding because the process is very slow
compared to globular proteins, and the kinetics of
folding can be obtained in real time by NMR. Studies on
triple-helical peptides illustrate the ability to observe
kinetic folding intermediates directly and the ability to
propose detailed mechanisms of folding through the
use of real-time NMR methods. Defective collagen
folding has been implicated in various connective
tissue diseases and the capacity of NMR to look at the
folding of specific sites provides a tool for obtaining
information about altered folding mechanisms.
Comparison of folding in peptides that model normal
and diseased collagens could shed light on the
molecular perturbation and the etiology of disease.
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Introduction
NMR spectroscopy has become an important tool in the
elucidation of protein folding intermediates and path-
ways [1–4]. Real-time NMR folding studies have been
used to follow unfolding of proteins [5], to probe slow
folding events such as proline isomerization [6–9], and to
monitor transient folding intermediates that resemble a
molten globule state [10]. Most NMR studies have
focused on globular proteins which are composed typi-
cally of -helices, -sheet, and -bends. Recently, there
has been increased appreciation of the importance and
widespread nature of multichain supercoiled motifs
found in fibrous proteins, namely the collagen triple helix
and the coiled-coil -helix [11]. The triple helix has been
recognized as a binding and structural motif in a large
family of collagens and a variety of host-defense proteins
[12,13]. These supercoiled systems present unusual chal-
lenges for NMR studies as a result of their multichain
nature, repetitive sequence patterns, symmetry, and
elongated rod-like shapes.
The coiled coil and triple helix provide simple systems for
studying the interactions that govern folding in oligomeric
proteins. Folding and association are concerted processes
for coiled-coil and triple-helix fibrous proteins. Coiled-coil
structures undergo this process on a millisecond to second
timescale, similar to that seen for monomeric globular pro-
teins [14,15]. In contrast, the collagen triple helix folds
slowly, on a timescale of minutes to hours. The slow
folding makes the triple-helix system amenable to NMR
monitoring of real-time kinetics [16]. NMR studies on the
collagen triple helix have been reviewed recently [17], and
here we discuss the application of multidimensional NMR
spectroscopy to folding in triple-helical peptides.
The collagen triple helix
The collagen triple helix is a supercoiled assembly of
three extended polyproline II like chains, stabilized by a
high content of the imino acids proline and hydroxypro-
line (Hyp, or O in the one-letter amino acid code), the
presence of glycine as every third residue, and an exten-
sive hydration network [18,19]. This leads to the repeti-
tive sequence pattern (Gly-X-Y)n, where X and Y can be
any amino acids but are frequently Pro and Hyp. Charac-
terization of the sequence-dependent properties of the
triple helix is critical to understanding its biological role
and the interactions that determine folding. The Gly, Pro
and Hyp residues are required for stabilization of the
triple-helical molecule. The charged, polar, and hydropho-
bic residues in X and Y positions are instrumental in the
formation of higher-order structures, such as fibrils and
binding of other molecules. For instance, electrostatic and
hydrophobic interactions are known to be critical for the
assembly of collagen molecules into D-periodic fibrils [20]
and similar interactions must be involved in the binding of
collagen to molecules such as integrins, fibronectin, matrix
metalloproteinases, and phospholipid vesicles [21]. The
requirement for Gly-X-Y sequence variations to specify
interactions must be balanced with sufficient imino acid
content to ensure collagen stability at body temperature. 
The folding of the collagen triple helix requires a transi-
tion from denatured monomers to a supercoiled helical
trimer. This process has been shown to require an initial
nucleation step followed by propagation [22]. The collagen
molecule is synthesized in a precursor form, procollagen,
which has N- and C-terminal globular propeptides. During
in vivo folding, the globular C-propeptides facilitate chain
association, registration and nucleation [23]. Nucleation of
the triple helix takes place at the Gly-Pro-Hyp-rich C ter-
minus. This is followed by a C→N-terminal zipper-like
propagation, which is limited by the slow cis/trans isomer-
ization of X-Pro imide bonds [24].
Defective folding of mutant collagens has been implicated
in a number of connective tissue diseases [25]. In most
cases of brittle bone disease (osteogenesis imperfecta
[OI]), for example, a single Gly in the (Gly-X-Y)n repeat-
ing sequence is replaced by another amino acid, and these
substitutions have been shown to slow down triple-helix
folding [26]. NMR studies on peptides that model these
regions with mutations provide an approach for defining
the folding defect at a molecular level and shedding light
on the etiology of human collagen diseases.
Peptide design
Peptides serve as useful models for the collagen triple
helix and are suitable for NMR studies. Using solid state
peptide synthesis technology, triple-helical peptides of
defined length and sequence can be made. A stable
triple-helical conformation will be adopted if peptides
have Gly as every third residue and a high content of
imino acids. The most stabilizing Gly-X-Y tripeptide
sequence is Gly-Pro-Hyp, and inclusion of (Gly-Pro-
Hyp)n sequences at one or both ends of peptides has
served as the basis of many peptide designs. For
instance, (Pro-Hyp-Gly)10 forms a triple helix with a
melting point near 60°C in aqueous solution, while (Pro-
Hyp-Gly)4-Glu-Lys-Gly-(Pro-Hyp-Gly)5 has a Tm near
42°C [27] and (Pro-Hyp-Gly)3-Ile-Thr-Gly-Ala-Arg-Gly-
Leu-Ala-Gly-(Pro-Hyp-Gly)4 has a Tm near 25°C [28].
An additional strategy for stabilization has been covalent
cross-linking of the three chains in the triple helix. The
synthesis of peptides on a Lys-Lys dimer base has been
one approach to synthesizing a variety of cross-linked
trimer peptides containing simple sequences as well as
biologically important collagen binding sites [29]. More
recently, Goodman and colleagues have used a rigid Kemp
triacid (KTA) template for attachment of three (Gly-Pro-
Hyp)n chains, where the length n is varied [30,31]. The
KTA approach was also applied to the incorporation of
(Gly-Pro-Nleu)n chains (where Nleu is the peptoid
residue N-isobutylglycine) [32]. The attachment of the
peptide chains to a KTA template was shown to have a
very strong stabilizing effect on the triple-helical confor-
mation and to greatly accelerate folding.
All of the peptides described above form triple helices
with three identical chains. A very significant advance has
been made with the report of a heterotrimeric cross-linked
triple-helical peptide that acts as a substrate for human
neutrophil collagenase [33]. The design strategy utilized
inclusion of cysteine residues at positions that would facil-
itate formation of two interstrand disulfide bridges
keeping the three chains in correct register.
Triple-helical peptides that are not cross-linked, and those
cross-linked on a KTA template, have proved to be highly
soluble in aqueous solution and have been used for NMR
conformation and dynamic studies. The folding of the
triple helix is very slow for peptides that are not cross-
linked and real-time NMR studies of this process have
been reported on such designed peptides [16]. Cross-
linking has been shown to greatly accelerate the folding of
the triple helix, so that it is complete within fractions of a
minute and no longer suitable for NMR investigation.
NMR studies on triple-helical peptides with repeating
tripeptide sequences
Collagen-like peptides are well suited for NMR studies
because of the high solubility of both the monomer and
the trimer forms, their relatively low molecular weight,
and their slow folding. However, the trimer form of these
peptides has intrinsic features that complicate structure
determination. Such features include its rod-like shape,
repetitive sequence, multichain composition, and symme-
try. The triple helix is an extended uniform conformation,
giving rise to a rod-like molecule, so that even a 30-
residue peptide has an axial ratio of greater than 8:1, as
seen in Figure 1. This leads to anisotropic tumbling which
results in the broadening of NMR peaks expected for a
much higher molecular weight molecule and the depen-
dence of NOE intensities on the internuclear 1H–1H
vector and the long axis of the molecule [34,35]. 
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Figure 1
Schematic representation of the collagen-like
triple-helical peptide T3-785, which includes
Pro-Hyp-Gly (POG) sequences at both ends
and a central nine-residue sequence from
human type III collagen (dark section). The
dimensions of the peptide are shown,
indicating the rod-like shape of the molecule.
The sequence for peptide T3-785 and the
one-residue stagger between the three chains
are shown beneath.
Multidimensional NMR studies have been reported on
simple repeating polytripeptides, such as (Pro-Hyp-
Gly)10, and shorter cross-linked peptides containing
repeating Gly-Pro-Hyp or Gly-Pro-Nleu sequences
[28,36–38]. Proton NMR including TOCSY, COSY and
NOESY experiments have been used to obtain sequence-
specific assignments for the repeating triplet unit in these
peptides, but overlapping resonances prevent assign-
ments to individual chains [28,37,38]. Because of the
inability to distinguish different chains and the identical
repetitive sequence within a given chain, an NOE cross-
peak may arise from interactions between atoms in the
same chain and/or between atoms from different chains.
For example, an NOE between Gly-NH and Hyp-CH
can arise from either an interchain or an intrachain inter-
action. Direct structural determination based on NOE-
derived distance constraints is therefore not possible. An
initial structural approach is taken by using the X-ray-
derived triple-helix model to determine which NOEs
arise uniquely from interchain interactions [28,37,38].
The observation of these NOEs confirms that the basic
triple-helix model is present in solution in (Pro-Hyp-
Gly)10 and in the cross-linked peptides. The repetitive
sequence and the stabilizing nature of Gly-Pro-Hyp
triplets makes the peptide (Pro-Hyp-Gly)10 a useful stan-
dard to compare with peptides with more varied
sequences that model collagen.
NMR conformation and dynamics studies on a collagen
model peptide 
Approaches to gain more specific information about col-
lagen through the use of NMR include the incorpora-
tion of collagen-like non-identical tripeptide sequences
and the labeling of residues at specific positions in pep-
tides (Figure 1). A collagen sequence was incorporated
into peptide T3-785, the conformation, dynamics and
folding of which were extensively studied by NMR
[16,28,35]. Uniform labeling with 13C or 15N is not eco-
nomically feasible on peptides and, furthermore, colla-
gen molecules cannot be produced in bacterial
expression systems because bacteria do not have the
enzymes for posttranslational modification of proline to
hydroxyproline. However, synthesis of peptides with
15N-enriched residues at specific sites has provided an
alternative approach.
Studies on T3-785 illustrate the effect of amino acid
sequence on triple-helix properties and show the advan-
tages of incorporating specifically labeled residues.
Peptide T3-785 was designed to incorporate residues of
type III collagen in the middle of a sequence that has
Pro-Hyp-Gly caps at both ends for stabilization
(Figure 1). This sequence is imino acid deficient and
represents a biologically important region of collagen
[28]. It is located C-terminal to the unique collagenase
site (781–782) and includes the single trypsin cleavage
site at residue 790. This peptide adopts a triple-helical
conformation at low temperature, but is considerably less
stable than (Pro-Hyp-Gly)10.
To determine the conformation of the triple-helical
peptide, one version of T3-785 was made with an 15N-
enriched tripeptide unit Gly-Leu-Ala [28]. The proton
and 15N resonances of T3-785 are assigned using HMQC,
HMQC-NOESY and HMQC-TOCSY experiments [28].
The signals for the Gly, Leu and Ala residues are well
resolved in the HMQC spectrum (Figure 2). Each residue
shows four peaks which arise from the monomer/trimer
equilibrium. One peak in the spectrum does not disappear
as a function of temperature and corresponds to a
monomer species. As the peptide is heated above the
melting temperature, three of the peaks disappear, indi-
cating that these derive from the triple-helix conforma-
tion. Sequential connectivities in the NOESY spectrum at
low temperature can be traced for three distinct chains of
the trimer, and NOEs between these chains indicate close
packing in a conformation similar to that seen in the triple-
helix model deduced by X-ray diffraction. This indicates
that the three resonances for each residue represent three
distinguishable chains in one trimer of peptide T3-785.
The one-residue stagger between the three chains in the
molecule results in non-equivalent environments when
the triplets along the chain are nonrepetitive, as is the case
for Gly-Leu-Ala in T3-785.
To further characterize the amino acid sequence depen-
dence of the trimer state, the backbone dynamics of T3-
785 and (Pro-Hyp-Gly)10 were compared [35] (Table 1).
15N relaxation and hydrogen exchange experiments were
obtained for the labeled Gly-Leu-Ala residues in T3-785
and for a labeled Gly residue in the middle of the
peptide (Pro-Hyp-Gly)10. An anisotropic treatment of the
data is required to obtain order parameters from the 15N
relaxation experiments because of the rod-like dimen-
sions of these molecules. The values of the order para-
meters for the Gly in (Pro-Hyp-Gly)10 and for the
labeled residues in T3-785 are similar to one another and
resemble those found in secondary structures of globular
proteins. This suggests a rigidity on the picosecond
timescale that is independent of sequence and stability.
In contrast, hydrogen exchange rates were seen to be
much faster for the Gly in T3-785 than for the Gly in
(Pro-Hyp-Gly)10. Studies on homologous sets of peptides
suggest that hydrogen exchange of amide groups in the
triple helix proceeds by an EX2 mechanism and reflects
local stability and dynamics, rather than global stability
or folding (D Siegel, J Baum, unpublished data). Varia-
tions in local dynamic properties such as seen for T3-785
and (Pro-Hyp-Gly)10 could play a role in recognition and
folding. Thus the backbone conformation shows little
sequence dependence, while the dynamics are affected
by sequence.
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Real-time NMR folding of a collagen model peptide
The folding of peptide T3-785 takes place over a period of
hours. This slow rate of folding, together with the NMR
assignments of both monomer and trimer peaks, sets the
stage for direct monitoring of the kinetics of folding [16].
The folding of peptide T3-785 illustrates some of the fea-
tures of real-time NMR folding of triple-helical peptides
and the sequence dependence of triple-helix formation. 
Multiple peptides with labeled residues in different posi-
tions are synthesized in order to probe the directional
nature of the folding process by real-time NMR. An
example of one peptide with labeled residues in the
central region and at the C-terminal end is shown in
Figure 3a [16]. During the folding process, the kinetics of
folding can be monitored by following the decrease in the
intensity of the monomer peaks and/or the increase in the
intensity of the trimer peaks. Figure 3b shows the kinetics
of folding for spectra acquired 30 s after initiation of
folding. The data show that the formation of the trimer
and the loss of the monomer intensity for the Ala in the
center of the chain (Ala13) is slower than for the Gly
residue near the C terminus (Gly24). This disparity in
initial amplitudes indicates that the C-terminal end is
folding into the trimer form more rapidly than the central
region, and that there is a point in the folding process
where the local conformation of Gly24 is in a triple-helical
form while the central Ala is still in the unfolded state.
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Figure 2
(a) Peptide T3-785 with an 15N-labeled Gly15-Leu16-Ala17 tripeptide
(shown in bold and underlined). (b) HMQC spectrum of T3-785
dissolved in 90% H20/10% D2O solution (pH 2.6) at 10°C. The four
peaks seen for 15N-labeled Gly*, Leu*, and Ala* residues are indicated.
The superscript D refers to the ‘denatured’ peak for each residue, and
the other three peaks represent the three chains in the trimer form. For
example, 1G, 2G, and 3G are Gly from chains 1, 2, and 3, respectively.
Two trimer Ala peaks were not assigned due to chemical shift overlap.
(c) HMQC-NOESY spectrum of T3-785 dissolved in D2O at 10°C,
showing the NH and CH region of the spectrum. 15N was not
decoupled during the acquisition time. The sequential connectivities of
chain 1 are fully traced out, and the sequence 1R-1G*-1L*-1A* is
connected by a solid line. The boxed regions are the positions of the
HMQC-TOCSY peaks. The circled peaks are the interchain NOEs.
Table 1
Order parameter (S2), hydrogen exchange rate (kex) and
protection factor (P) for 15N-Gly15 in the peptides T3-785 and
(Pro-Hyp-Gly)10 at 10°C [35].
Peptide S2 kex (× 10–4 min–1) P
T3-785 0.85 ± 0.03 0.5 1077
(Pro-Hyp-Gly)10 0.88 ± 0.04 < 0.04 > 104
This state must represent a kinetic intermediate in the
folding of triple-helical peptides. In addition, the kinetic
orders in the terminal and central regions are different
from one another. The C-terminal Gly folds with second-
order kinetics, while the central Ala residue follows first-
order kinetics. 
Taken together, the NMR data are consistent with a
simple mechanism of association/nucleation which is rep-
resented by the second-order kinetics of the terminal end,
followed by propagation which is represented by the first-
order kinetics of the central region of the peptide
(Figure 3c). In the first step, the monomer chains associate
to form dimers. The ‘nucleated trimer’ species, in which
Gly24 is in a helical environment while Ala13 is still in an
unfolded environment, are formed in the second step.
The last step of the folding mechanism is a slow first-order
propagation step where the nucleated species propagates
into a triple helix. In the schematic drawing, the trimer is
nucleated at one end; however, additional studies with
Gly labeled at the N-terminal end indicate that nucleation
can occur from either the C-terminal or N-terminal end.
The real-time NMR data on residues at different sites
provide kinetic rate constants for both the nucleation and
propagation steps in the folding process. These rate con-
stants indicate that the nucleation and propagation steps
are both slow in T3-785. The sequence-dependent nature
of the individual steps in triple-helix folding can be inves-
tigated by NMR. Comparison of different peptides with
labeled residues at comparable positions show the effect
of sequence environment on folding. For example, the
central Gly residue in (Pro-Hyp-Gly)10 folds at a much
faster rate compared with Gly in the same position in
peptide T3-785 (J Baum, X Liu, unpublished data). One
factor may be the effect of amino acid sequence on the
conformation of the unfolded monomer form. The high
content of sequences such as Gly-Pro-Hyp, which have a
strong propensity for extended forms or -bends, makes
the denatured single chain form of triple-helical peptides
unlikely to be approximated by a random coil type struc-
ture and therefore amenable to characterization by NMR
[39,40]. It has been suggested that an extended conforma-
tion is more favorable for folding [41]. Preliminary NMR
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Figure 3
(a) Peptide T3-785 with 15N-labeled Gly24 and Ala13. (b) NMR
folding profiles for Gly24 (filled circles) and Ala13 (filled squares). The
disappearance of the monomer peaks (solid line) and the appearance
of the trimer peaks (dashed line) is faster for Gly24 than for Ala13. The
lines for Gly24 are second-order fits to the data and the lines for Ala13
are first-order fits to the data. (c) Proposed three-step folding
mechanism for T3-785 (see text).
Figure 4
The triple helix of type I collagen is
represented at the top. Several sites of
osteogenesis imperfecta (OI) Gly→Ser
mutations are indicated. The region around
mutations at 901 and 913 is expanded
showing the amino acid sequence 892–921
of the 1 chain of type I collagen. The amino
acid sequence incorporated into peptide T1-
892 is underlined.
studies suggest that the monomer is nonrandom, with the
central imino acid poor region in monomer T3-785 less
extended than the central Pro-Hyp-Gly sequence in (Pro-
Hyp-Gly)10.
Peptide models of collagen folding diseases
NMR investigations of conformation, dynamics and
folding at specific sites along the triple helix can be
applied to peptides that model collagen mutations in
disease. The best characterized collagen disease is osteo-
genesis imperfecta (OI), which results from mutations in
the 1 or 2 chains of type I collagen, the major collagen
in bone [25]. The majority of OI cases have a Gly→X sub-
stitution at one site as seen in Figure 4. It appears that a
pathological condition results from a Gly replacement at
any site along the triple-helix domain where it breaks the
(Gly-X-Y)n pattern. In general, lethal mutations of OI
appear to be clustered in the C-terminal 60% of the mole-
cule, while those near the N terminus are nonlethal. This
suggests a relationship to the directional propagation of the
triple helix, in a C→N-terminal direction. Experimental
evidence supports the concept that the Gly-substituted
collagens represent folding mutations. Such evidence
includes direct observation of delayed folding and
increased posttranslational modification (which occurs only
on unfolded chains) [25,26,42]. The nature of the folding
defect remains to be defined, and NMR studies of pep-
tides with Gly substitutions offer an opportunity to charac-
terize folding at the substitution site, as well as other
positions relative to the mutation site along the peptide.
Gly substitutions were introduced first in the highly sim-
plified repeating model peptide (Pro-Hyp-Gly)10 [43,44]
and more recently in peptide T1-892 which contains the
real sequence around an OI site [45]. Peptide T1-892 was
synthesized to contain a region of the 1 chain of type I
collagen where a nonlethal mutation was identified (site
901; see Figure 4). In T1-892, an 18-residue sequence of
the collagen chain around the 901 mutation site was
capped at the C terminus with the stabilizing (Gly-Pro-
Hyp)4 sequence to promote nucleation. A homologous
peptide was synthesized that contained the Gly901→Ser
substitution to model the case of a mild OI mutation:
peptide T1-892(G→S). In CD studies (Figure 5), the
thermal stability is decreased substantially by the
Gly901→Ser substitution, while the folding rate was little
affected. For both T1-892 and T1-892(G→S), the CD
folding data fit second-order kinetics best, implying that
the nucleation step is rate limiting and not affected by the
Gly901→Ser substitution.
An understanding of the folding behavior of these OI
peptides can be greatly enhanced by NMR real-time
folding studies on peptides. Using specifically labeled
residues, the nucleation and propagation steps can be
discriminated and the effect of the Gly→Ser substitution
can be understood in terms of the specific steps in the
folding mechanism (J Baum, B Brodsky, unpublished
data) [16]. To investigate the substitution site itself, as
well as residues upstream and downstream, several forms
of peptides T1-892 and T1-892(G→S) were synthesized
with specific 15N-enriched residues (Figure 6). NMR
studies indicate that for T1-892, nucleation takes place
exclusively at the C terminus, followed by propagation.
The unidirectional folding of T1-892 contrasts with the
bidirectional folding of T3-785 and leads to an excellent
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Figure 5
(a) Thermal equilibrium curves for T1-892 (solid line) and for T1-
892(G→S) (dashed line) as monitored by CD at 225 nm. Both
peptides contain residues 892–909 of the 1 chain of type I
collagen, and one has the Gly→Ser substitution at position 901.
(b) Folding kinetics of peptides T1-892 (filled circles) and T1-
892(G→S) (open circles) at 2°C, pH 7. The change in ellipticity was
monitored at 225 nm.
model for collagen folding. The T1-892 peptide also
folds much more slowly than T3-785 and has a more
complicated mechanism of folding.
In T1-892 and T1-892(G→S), NMR experiments indi-
cate that the folding of the C-terminal residues involved
in nucleation are similar to one another, but the folding
of residues near the substitution site are very different
from one another (J Baum, X Liu, unpublished data). In
T1-892, for example, the accumulation of a kinetic
intermediate at Ala12 can be detected directly in the
NMR spectra and the kinetic folding profile of this
intermediate along with the loss of monomer and slow
trimer formation are shown in Figure 6a. From these
kinetic data, it is proposed that for T1-892, at least one
first-order conformational rearrangement occurs after
the ‘nucleated trimer’ step shown in Figure 3c and
before the formation of the final trimer. NMR studies on
the Gly→Ser peptide indicate that it has a less ordered
folded form than T1-892 (X Liu, J Baum, unpublished
data), and the same Ala12 in the Gly→Ser peptide
(Figure 6b) folds to its final form faster than seen for
T1-892, at a rate similar to that seen for the formation of
the T1-892 intermediate. Further analysis of the data
should allow the definition of the folding mechanism in
the mutated peptides, and the steps at which alterations
are occurring.
Conclusions
Collagen triple-helical peptides offer a simple and
uniform model for studying protein folding in the
context of chain association and supercoiled helices. The
slow folding rate of the triple helix makes it amenable to
real-time NMR studies. Through the use of labeled
residues at specific positions, individual steps in the
folding process have been defined. The discrimination
and observation of kinetic intermediates will allow clari-
fication of the interactions that are important in chain
association and propagation. Given the Gly-X-Y repeat-
ing unit of the triple helix, the identity of the X and Y
residues must determine the factors important in folding.
The lack of hydrophobic stabilization of the triple helix
[46] makes it likely that the nature of these factors will
be different than for those seen for globular proteins. In
particular, it will be interesting to compare the sequence
dependence of the formation of triple helices with the
folding of small dimeric proteins with a more conven-
tional hydrophobic core [47–51]. In addition to defining
basic folding mechanisms, NMR studies on the triple
helix have made it possible to examine perturbations at
collagen mutation sites. Future studies will be directed
toward clarifying the folding defects in lethal as well as
nonlethal mutation sites to see whether the degree of
clinical severity can be correlated with the altered
folding mechanism.
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Figure 6
(a) NMR folding profile for Ala12 in peptide T1-892. The sequence of
T1-892 is shown at the top; the shaded residue is the mutation site,
the bold underline shows the position of 15N-labeled residues in the
peptide that have been monitored by NMR and the arrow indicates the
15N-labeled Ala12 shown in this figure. The disappearance of the
monomer peak (circles), the appearance of the trimer peak (squares)
and the direct detection of a kinetic intermediate (triangles) are
indicated. The lines are drawn to aid the eye. (b) NMR folding profile
for Ala12 in the T1-892(G→S) peptide. The sequence is shown at the
top, with the mutation site shaded, the 15N-labeled positions shown as
bold underline and the 15N-labeled Ala12 shown in the figure
indicated by an arrow. The disappearance of the monomer peak
(circles) and the appearance of the trimer peak (squares) are indicated
and the lines are drawn to aid the eye. In contrast to T1-892, there is
no accumulation of a kinetic intermediate in the kinetic folding profile
of the T1-892(G→S) peptide.
References
1. Baldwin, R.L. (1993). Pulsed H/D-exchange studies of folding interme-
diates. Curr. Opin. Struct. Biol. 3, 84–91.
2. Dobson, C.M. (1994). Solid evidence for molten globules. Curr. Opin.
Struct. Biol. 4, 636–640.
3. Ptitsyn, O.B. (1995). Structures of folding intermediates. Curr. Opin.
Struct. Biol. 5, 74–78.
4. Miranker, A.D. & Dobson, C.M. (1996). Collapse and cooperativity in
protein folding. Curr. Opin. Struct. Biol. 6, 31–42.
5. Kiefhaber, T., Labhardt, A.M. & Baldwin, R.L. (1995). Direct NMR evi-
dence for an intermediate preceding the rate-limiting step in the unfold-
ing of ribonuclease A. Nature 375, 513–515.
6. Blum, A.D., Smallcombe, S.H. & Baldwin, R.L. (1978). Nuclear mag-
netic resonance evidence for a structural intermediate at an early stage
in the refolding of ribonuclease A. J. Mol. Biol. 118, 305–315.
7. Adler, M. & Scheraga, H.A. (1988). Structural studies of a folding inter-
mediate of bovine pancreatic ribonuclease A by continuous recycled
flow. Biochemistry 27, 2471–2480.
8. Akasaka, K., Naito, A. & Nakatani, H. (1991). Temperature-jump NMR
study of protein folding: ribonuclease A at low pH. J. Biomol. NMR 1,
65–70.
9. Koide, S., Dyson, H.J. & Wright, P.E. (1993). Characterization of a
folding intermediate of apoplastocyanin trapped by proline isomeriza-
tion. Biochemistry 32, 12299–12310.
10. Balbach, J., Forge, V., Van Nuland, N.A.J., Winder, S.L., Hore, P.J. &
Dobson, C.M. (1995). Following protein folding in real time using NMR
spectroscopy. Nat. Struct. Biol. 2, 865– 870.
11. Brodsky, B. (1990). Folding and higher order structure in fibrous pro-
teins. In The Protein Folding Problem. (Gierasch, L. & King, J., eds.),
pp. 55–62, AAAS, Washington.
12. Brodsky, B. & Shah, N.K. (1995). Folding and higher order structure in
fibrous proteins. FASEB J. 9, 1537–1546.
13. Cohen, C. & Parry, D.A.D. (1986). -Helical coiled coils: a widespread
motif in proteins. Trends Biochem. Sci. 11, 245–248.
14. Wendt, H., Berger, C., Baici, A., Thomas, R.M. & Bosshard, H.R.
(1995). Kinetics of folding of leucine zipper domains. Biochemistry 34,
4097–4107.
15. Zitzewitz, J.A., Bilsel, O., Luo, J., Jones, B.E. & Matthews, C.R. (1995).
Probing the folding mechanism of a leucine zipper peptide by stopped-
flow circular dichroism spectroscopy. Biochemistry 34, 12812–12819.
16. Liu, X., Siegel, D.L., Fan, P., Brodsky, B. & Baum, J. (1996). Direct NMR
measurement of the folding kinetics of a trimeric peptide. Biochemistry
35, 4306–4313.
17. Mayo, K.H. (1996). NMR and X-ray studies of collagen model peptides.
Biopolymers 40, 359–370.
18. Bella, J., Eaton, M., Brodsky, B. & Berman, H.M. (1994). Crystal and
molecular structure of a collagen-like peptide at 1.9 Å resolution.
Science 266, 75–81.
19. Rich, A. & Crick, F.H.C. (1961). The molecular structure of collagen. J.
Mol. Biol. 3, 483–506.
20. Hulmes, D.J.S., Miller, A., Parry, D.A.D., Piez, K.A. & Woodhead-Gal-
loway, J. (1973). Analysis of the primary structure of collagen for the
origins of molecular packing. J. Mol. Biol. 79, 137–148.
21. Kadler, K. (1994). Extracellular matrix I. Fibril forming collagens. Protein
Profile 1, 519–638.
22. Bächinger, H.P., Bruckner, P., Timpl, R. & Engel, J. (1978). The role of
cis-trans isomerization of peptide bonds in the coil ⇔ triple helix con-
version of collagen. Eur. J. Biochem. 90, 605–613.
23. Prockop, D.J. & Kivirikko, K.I. (1995). Collagens: molecular biology, dis-
eases, and potentials for therapy. Annu. Rev. Biochem. 64, 403–434.
24. Engel, J. & Prockop, D.J. (1991). The zipper-like folding of collagen
triple-helices and the effects of mutations that disrupt the zipper. Annu.
Rev. Biophys. Biophys. Chem. 20, 137–152.
25. Byers, P.H. (1993). Osteogenesis imperfecta. In Connective Tissue
and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects.
(Royce, P.M. & Steinmann, B., eds.), pp. 351–407, Wiley Liss, New
York.
26. Raghunath, M., Bruckner, P. & Steinmann, B. (1994). Delayed triple
helix formation of mutant collagen from patients with osteogenesis
imperfecta. J. Mol. Biol. 236, 940–949.
27. Venugopal, M.G., Ramshaw, J.A.M., Braswell, E., Zhu, D. & Brodsky, B.
(1994). Electrostatic interactions in collagen-like triple-helical peptides.
Biochemistry 33, 7948–7956.
28. Li, M.-H., Fan, P., Brodsky, B. & Baum, J. (1993). Two-dimensional
NMR assignments and conformation of (Pro-Hyp-Gly)10 and a
designed collagen-like triple-helical peptide. Biochemistry 32,
7377–7387.
29. Fields, G.B. & Prockop, D.J. (1996). Perspectives on synthesis and
applications of triple-helical collagen model peptides. Biopolymers 40,
345–357.
30. Feng, Y., Melacini, G., Taulane, J.P. & Goodman, M. (1996). Acetyl-ter-
minated and template-assembled collagen-based polypeptides com-
posed of Gly-Pro-Hyp sequences. 2. Synthesis and conformational
analysis by circular dichroism, ultraviolet absorbance, and optical rota-
tion. J. Am. Chem. Soc. 118, 10351–10358.
31. Goodman, M., Feng, Y., Melacini, G. & Taulane, J.P. (1996). A tem-
plate-induced incipient collagen-like triple-helical structure. J. Am.
Chem. Soc. 118, 5156–5157.
32. Goodman, M., Melacini, G. & Feng, Y. (1996). Collagen-like triple
helices incorporating peptoid residues. J. Am. Chem. Soc. 118,
10928–10929.
33. Ottl, J., et al., & Moroder, L. (1996). Design and synthesis of het-
erotrimeric collagen peptides with a built-in cystine knot. FEBS Lett.
398, 31–36.
34. Withka, J.M., Swaminathan, S. & Bolton, P.H. (1990). NOEs in duplex
DNA depend on orientations of internuclear vectors to the symmetry
axis. J. Magn. Res. 89, 386–390.
35. Fan, P., Li, M.-H., Brodsky, B. & Baum, J. (1993). Backbone dynamics
of (Pro-Hyp-Gly)10 and a designed collagen-like triple helical peptide
by 15N NMR relaxation and hydrogen exchange measurements. Bio-
chemistry 32, 13299–13309.
36. Brodsky, B., Li, M.-H., Long, C.G., Apigo, J. & Baum, J. (1992). NMR
and CD studies of triple-helical peptides. Biopolymers 32, 447–451.
37. Melacini, G., Feng, Y. & Goodman, M. (1996). Acetyl-terminated and
template-assembled collagen-based polypeptides composed of Gly-
Pro-Hyp sequences. 3. Conformational analysis by 1H-NMR and molec-
ular modeling studies. J. Am. Chem. Soc. 118, 10359–10364.
38. Melacini, G., Feng, Y. & Goodman, M. (1996). Collagen-based struc-
tures containing the peptoid residue N-isobutylglycine (Nleu). 2. Con-
formational analysis of Gly-Pro-Nleu sequences by 1H NMR, CD, and
molecular modeling. J. Am. Chem. Soc. 118, 10725–10732.
39. Dyson, H.J. & Wright, P.E. (1993). Peptide conformation and protein
folding. Curr. Opin. Struct. Biol. 3, 60–65.
40. Mayo, K.H., Parra-Diaz, D., McCarthy, J.B. & Chelberg, M. (1991). Cell
adhesion promoting peptide GVKGDKGNPGWPGAP from collagen
type IV triple helix: cis/trans proline-induced multiple 1H NMR confor-
mations and evidence for a KG/PG multiple turn repeat motif in the all-
trans proline state. Biochemistry 30, 8251–8267.
41. Chopra, R.K. & Ananthanaryanan, V.S. (1982). Conformational implica-
tions of enzymatic proline hydroxylation in collagen. Proc. Natl Acad.
Sci. USA 79, 7180–7184.
42. Bächinger, H.P., Morris, N.P. & Davis, J.M. (1993). Thermal stability and
folding of the collagen triple helix and the effects of mutations in osteo-
genesis imperfecta on the triple helix of type I collagen. Am. J. Med.
Gen. 45, 152–162.
43. Long, C.G., Braswell, E., Zhu, D., Apigo, J., Baum, J. & Brodsky, B.
(1993). Characterization of collagen-like peptides containing interrup-
tions in the repeating Gly-X-Y sequence. Biochemistry 32,
11688–11695.
44. Long, C.G., Li, M.-H., Baum, J. & Brodsky, B. (1992). Nuclear magnetic
resonance and circular dichroism studies of a triple-helical peptide with
a glycine substitution. J. Mol. Biol. 225, 1–4.
45. Yang, W., Battinenni, M. & Brodsky, B. (1997). Amino acid sequence
environment modulates the disruption by osteogenesis imperfecta
glycine substitutions in collagen-like peptides. Biochemistry 36,
6930–6935.
46. Shah, N.K., Ramshaw, J.A.M., Kirkpatrick, A., Shah, C. & Brodsky, B.
(1996). A host-guest set of triple helical peptides: stability of Gly-X-Y
triplets containing common nonpolar residues. Biochemistry 35,
10262–10268.
47. Milla, M.E. & Sauer, R.T. (1994). P22 Arc repressor: folding kinetics of
a single-domain, dimeric protein. Biochemistry 33, 1125–1133.
48. Waldburger, C.D., Jonsson, T. & Sauer, R.T. (1996). Barriers to protein
folding: formation of buried polar interactions is a slow step in acquisi-
tion of structure. Proc. Natl Acad. Sci. USA 93, 2629–2634.
49. Mok, Y.-K., Bycroft, M. & De Prat-Gay, G. (1996). The dimeric DNA
binding domain of the human papillomavirus E2 protein folds through a
monomeric intermediate which cannot be native-like. Nat. Struct. Biol.
3, 711–717.
50. Munson, M., Anderson, K.S. & Regan, L. (1997). Speeding up protein
folding: mutations that increase the rate at which Rop folds and unfolds
by over four orders of magnitude. Fold. Des. 2, 77–87.
51. Gittelman, M.S. & Matthews, C.R. (1990). Folding and stability of trp
aporepressor from Escherichia coli. Biochemistry 29, 7011–7020.
R60 Folding & Design Vol 2 No 4
